###begin article-title 0
###xml 57 64 57 64 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
Movement disorder and neuronal migration disorder due to ARFGEF2 mutation
###end article-title 0
###begin p 1
###xml 192 199 192 199 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 12 17 <span type="species:ncbi:9606">child</span>
We report a child with a severe choreadystonic movement disorder, bilateral periventricular nodular heterotopia (BPNH), and secondary microcephaly based on compound heterozygosity for two new ARFGEF2 mutations (c.2031_2038dup and c.3798_3802del), changing the limited knowledge about the phenotype. The brain MRI shows bilateral hyperintensity of the putamen, BPNH, and generalized atrophy. Loss of ARFGEF2 function affects vesicle trafficking, proliferation/apoptosis, and neurotransmitter receptor function. This can explain BPNH and microcephaly. We hypothesize that the movement disorder and the preferential damage to the basal ganglia, specifically to the putamen, may be caused by an increased sensitivity to degeneration, a dynamic dysfunction due to neurotransmitter receptor mislocalization or a combination of both.
###end p 1
###begin title 2
Electronic supplementary material
###end title 2
###begin p 3
The online version of this article (doi:10.1007/s10048-009-0192-2) contains supplementary material, which is available to authorized users.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 30 37 30 37 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 247 248 247 248 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 567 574 567 574 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
###xml 514 521 <span type="species:ncbi:9606">patient</span>
In 2004 mutations in the gene ARFGEF2 encoding ADP-ribosylation factor guanine nucleotide exchange factor 2, were found to cause autosomal recessive bilateral periventricular nodular heterotopia (BPNH) in four patients from two Turkish pedigrees [1]. Clinical features reported were microcephaly, feeding difficulties, severe mental retardation, quadriparesis, and epilepsy. More details on the phenotype were not reported and since then, to our knowledge, no additional patients have been published. We discuss a patient with a different phenotype caused by two new ARFGEF2 mutations.
###end p 6
###begin title 7
Case
###end title 7
###begin p 8
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 24 29 <span type="species:ncbi:9606">child</span>
Our patient is the only child of non-consanguineous parents from Dutch descent. Prenatal ultrasounds showed growth retardation. She was born at 38 weeks of gestation with an Apgar score of 10 after 5 min, birth weight 2,790 g, and length 46 cm. Occipito-frontal circumference was 34.2 cm at the age of 3 weeks (-1.5 SD). During the first year developmental delay became apparent. She showed social smiling at 2 months and grasping at 5 months, and rolled over at the age of 8 months. There were excessive extension movements. She had persistent feeding problems, severe drooling, and frequent vomiting. At the age of 9 months a pediatrician noted dystonic-spastic paraplegia with axial hypotonia. With physical therapy she showed some progression, but did not reach normal milestones. At the age of 4 years feeding difficulties prompted a gastrostomy. Despite adequate caloric intake, growth is unsatisfactory with height progressing at 2.5 SD below normal. Occipito-frontal circumference growth went from the -1.5 SD to 0.5 cm below the -2.5 SD curve. She never had seizures. Now, at the age of 7 years, she makes eye contact, smiles, and understands some words. She vocalizes, but does not produce any words. Pupillary responses are normal. There is no nystagmus. Axial muscle tone is low and variable in the extremities. Muscle strength is normal. She shows a severe extrapyramidal movement disorder with irregular repetitive jerking movements of all extremities and the face (chorea) and sustained abnormal movements and posturing (dystonia). This is exacerbated by emotions and during infections when large proximal jerking movements may resemble ballism. There is no rigidity or ataxia. Tendon reflexes are lively and symmetric, with extensor plantar responses (Babinski sign). She can sit with support, but cannot stand. The movement unrest can be so severe that she becomes exhausted and is partially responsive to treatment with high doses of benzodiazepines.
###end p 8
###begin p 9
###xml 365 366 365 366 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 738 744 738 744 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 791 792 791 792 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 794 795 794 795 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 801 802 801 802 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 852 853 852 853 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 855 856 855 856 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 862 863 862 863 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 866 867 866 867 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 872 873 872 873 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 982 993 982 993 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">black arrow</italic>
###xml 1003 1004 1003 1004 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1007 1008 1007 1008 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1013 1014 1013 1014 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1120 1131 1120 1131 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">white arrow</italic>
###xml 1141 1142 1141 1142 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1145 1146 1145 1146 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1151 1152 1151 1152 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1260 1261 1260 1261 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1283 1294 1283 1294 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">white arrow</italic>
###xml 744 1331 744 1331 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="10">Brain MRI made at the age of 13 months (images <italic>A</italic>, <italic>B</italic>, and <italic>C</italic>) and at the age of 4 years and 10 months (images <italic>D</italic>, <italic>E</italic>, and <italic>F</italic>). <italic>A</italic> and <italic>D</italic> T1-weighted images showing bilateral periventricular nodular heterotopia with the intensity of gray matter (<italic>black arrow</italic> in image <italic>D</italic>). <italic>B</italic> and <italic>E</italic> T2-weighted images showing hyperintensity of the putamen and atrophy of the putamen and globus pallidus (<italic>white arrow</italic> in image <italic>E</italic>). <italic>C</italic> and <italic>F</italic> Flair images, coronal view, showing bilateral hyperintensity of the putamen, more clearly visible on image <italic>F</italic> made at a later age (<italic>white arrow</italic>), and mild atrophy of the hippocampi</p>
###xml 744 1331 744 1331 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="10">Brain MRI made at the age of 13 months (images <italic>A</italic>, <italic>B</italic>, and <italic>C</italic>) and at the age of 4 years and 10 months (images <italic>D</italic>, <italic>E</italic>, and <italic>F</italic>). <italic>A</italic> and <italic>D</italic> T1-weighted images showing bilateral periventricular nodular heterotopia with the intensity of gray matter (<italic>black arrow</italic> in image <italic>D</italic>). <italic>B</italic> and <italic>E</italic> T2-weighted images showing hyperintensity of the putamen and atrophy of the putamen and globus pallidus (<italic>white arrow</italic> in image <italic>E</italic>). <italic>C</italic> and <italic>F</italic> Flair images, coronal view, showing bilateral hyperintensity of the putamen, more clearly visible on image <italic>F</italic> made at a later age (<italic>white arrow</italic>), and mild atrophy of the hippocampi</p></caption>
###xml 1331 1331 1331 1331 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="10048_2009_192_Fig1_HTML" id="MO1"/>
###xml 738 1331 738 1331 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="10">Brain MRI made at the age of 13 months (images <italic>A</italic>, <italic>B</italic>, and <italic>C</italic>) and at the age of 4 years and 10 months (images <italic>D</italic>, <italic>E</italic>, and <italic>F</italic>). <italic>A</italic> and <italic>D</italic> T1-weighted images showing bilateral periventricular nodular heterotopia with the intensity of gray matter (<italic>black arrow</italic> in image <italic>D</italic>). <italic>B</italic> and <italic>E</italic> T2-weighted images showing hyperintensity of the putamen and atrophy of the putamen and globus pallidus (<italic>white arrow</italic> in image <italic>E</italic>). <italic>C</italic> and <italic>F</italic> Flair images, coronal view, showing bilateral hyperintensity of the putamen, more clearly visible on image <italic>F</italic> made at a later age (<italic>white arrow</italic>), and mild atrophy of the hippocampi</p></caption><graphic xlink:href="10048_2009_192_Fig1_HTML" id="MO1"/></fig>
Brain MRI at the age of 13 months showed BPNH, myelination delay, and generalized atrophy, a second MRI at age 4 years and 10 months showed improved myelination, stable or minimally progressive generalized atrophy but also symmetric atrophy of the basal ganglia, specifically of the globus pallidus and the putamen with focal T2-hyperintensity of the putamen (Fig. 1). In retrospect, inhomogeneous abnormalities of the putamen can also be seen on the first MRI and suggest early degeneration resulting in gliosis. EEGs show delta-activity without differentiation or epileptiform activity. Metabolic testing of urine and plasma, including amino acids, lactate, pyruvate, and creatine kinase was normal. The family history is unremarkable. Fig. 1Brain MRI made at the age of 13 months (images A, B, and C) and at the age of 4 years and 10 months (images D, E, and F). A and D T1-weighted images showing bilateral periventricular nodular heterotopia with the intensity of gray matter (black arrow in image D). B and E T2-weighted images showing hyperintensity of the putamen and atrophy of the putamen and globus pallidus (white arrow in image E). C and F Flair images, coronal view, showing bilateral hyperintensity of the putamen, more clearly visible on image F made at a later age (white arrow), and mild atrophy of the hippocampi
###end p 9
###begin p 10
###xml 47 48 47 48 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 50 51 50 51 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 57 58 57 58 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 108 109 108 109 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 111 112 111 112 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 118 119 118 119 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 122 123 122 123 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 128 129 128 129 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 238 249 238 249 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">black arrow</italic>
###xml 259 260 259 260 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 263 264 263 264 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 269 270 269 270 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 376 387 376 387 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">white arrow</italic>
###xml 397 398 397 398 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 401 402 401 402 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 407 408 407 408 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 516 517 516 517 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 539 550 539 550 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">white arrow</italic>
Brain MRI made at the age of 13 months (images A, B, and C) and at the age of 4 years and 10 months (images D, E, and F). A and D T1-weighted images showing bilateral periventricular nodular heterotopia with the intensity of gray matter (black arrow in image D). B and E T2-weighted images showing hyperintensity of the putamen and atrophy of the putamen and globus pallidus (white arrow in image E). C and F Flair images, coronal view, showing bilateral hyperintensity of the putamen, more clearly visible on image F made at a later age (white arrow), and mild atrophy of the hippocampi
###end p 10
###begin p 11
###xml 75 82 75 82 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 535 536 535 536 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 539 545 539 545 <label xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 588 595 588 595 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 545 701 545 701 <p xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" textid="12">The sequences of the relevant areas of the <italic>ARFGEF2</italic> gene are depicted showing the maternal origin of c.2031_2038dup and the paternal origin of c.3798_3802del</p>
###xml 545 701 545 701 <caption xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="12">The sequences of the relevant areas of the <italic>ARFGEF2</italic> gene are depicted showing the maternal origin of c.2031_2038dup and the paternal origin of c.3798_3802del</p></caption>
###xml 701 701 701 701 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="10048_2009_192_Fig2_HTML" id="MO2"/>
###xml 539 701 539 701 <fig xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="12">The sequences of the relevant areas of the <italic>ARFGEF2</italic> gene are depicted showing the maternal origin of c.2031_2038dup and the paternal origin of c.3798_3802del</p></caption><graphic xlink:href="10048_2009_192_Fig2_HTML" id="MO2"/></fig>
Sequence analysis of all 39 coding exons and intron-exon boundaries of the ARFGEF2 gene on chromosome 20 shows compound heterozygosity for two variations that have not been previously reported. At the DNA level c.2031_2038dup and c.3798_3802del using reference sequence NM_006420.2 and at protein level p.Gln680ProfsX2 and p.Phe1267GlyfsX17, respectively. Both these variations lead to frame shift followed by a premature stop-codon and are therefore considered pathogenic mutations. Parents are heterozygote for found mutations (Fig. 2). Fig. 2The sequences of the relevant areas of the ARFGEF2 gene are depicted showing the maternal origin of c.2031_2038dup and the paternal origin of c.3798_3802del
###end p 11
###begin p 12
###xml 43 50 43 50 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
The sequences of the relevant areas of the ARFGEF2 gene are depicted showing the maternal origin of c.2031_2038dup and the paternal origin of c.3798_3802del
###end p 12
###begin title 13
Discussion
###end title 13
###begin p 14
###xml 13 20 13 20 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 123 124 123 124 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 854 855 854 855 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 131 138 <span type="species:ncbi:9606">patient</span>
Mutations in ARFGEF2 can cause autosomal recessive bilateral periventricular nodular heterotopia (BPNH) with microcephaly [1]. Our patient shows that a choreadystonic extrapyramidal movement disorder can be part of the phenotype. The movement disorder is reflected in MRI abnormalities of the basal ganglia, specifically of the putamen, in addition to generalized atrophy and BPNH. Anatomically, putamen and caudate nucleus form the dorsal striatum and are the major afferent center of the basal ganglia, receiving excitatory input from the cerebral cortex, thalamus, and brain stem. The putamen receives projections from the cortical motor and somatosensory areas, the midbrain, and the raphe nuclei. The striatum projects to the globus pallidus and substantia nigra, mainly with GABA-ergic neurons. Output is mediated by local inhibitory interneurons [2]. Similar choreadystonic movement disorders and putamen degeneration on MRI are seen in Huntington's disease, Wilson's disease and Leigh syndrome.
###end p 14
###begin p 15
###xml 353 354 353 354 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 567 568 567 568 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 569 570 569 570 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 692 693 692 693 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 695 696 695 696 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 698 699 698 699 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 701 702 701 702 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
ARFGEF proteins are guanine nucleotide exchange factors (GEFs) that activate ADP-ribosylation factors (ARFs). ARFGEF2 protein, also known as BIG2, is one of three GEFs expressed in the brain during the period of neural proliferation and migration with high expression in the cortical ventricular zone and ganglionic eminences, the future basal ganglia [1]. ARFs regulate the formation of coated vesicles from the Golgi, trans-Golgi network (TGN), and endosomes. In recycling endosomes BIG2 loss of function result in failure to deliver proteins to the cell membrane [3-5]. This was shown for the GABA(A) receptor, but also for the transferrin receptor and the tumor necrosis factor receptor [1, 4, 6, 7]. Other cell surface receptors are likely to be also affected.
###end p 15
###begin p 16
###xml 65 72 65 72 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 208 217 208 217 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">filamin A</italic>
###xml 224 228 224 228 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">FLNA</italic>
###xml 231 235 231 235 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">FLNA</italic>
###xml 338 339 338 339 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 468 472 468 472 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">FLNA</italic>
###xml 559 560 559 560 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 562 563 562 563 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 574 581 574 581 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 586 590 586 590 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">FLNA</italic>
###xml 707 708 707 708 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 891 892 891 892 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 894 896 894 896 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 945 949 945 949 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">FLNA</italic>
###xml 1040 1047 1040 1047 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 1269 1271 1269 1271 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1273 1275 1273 1275 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 18 25 <span type="species:ncbi:9606">patient</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 591 599 <span type="species:ncbi:9606">patients</span>
###xml 950 958 <span type="species:ncbi:9606">patients</span>
To understand our patient's phenotype, different consequences of ARFGEF2 loss of function need to be considered. The BPNH are similar to those seen in patients with loss-of-function mutations in the X-linked filamin A gene (FLNA). FLNA is the most commonly identified genetic cause for BPNH, found in approximately one third of patients [8]. In heterozygous females BPNH is associated with epilepsy and/or developmental delay or may be an accidental finding. In males FLNA mutations are often fatal, but may result in a similar phenotype to affected females [8, 9]. In both ARFGEF2 and FLNA patients the neuro-epithelium lining the ventricles is disrupted leading to failed migration of later-born neurons [9]. The similarity may be solely due to failed transport of the filamin A protein to the cell membrane by BIG2 dysfunction or to a final common pathway disrupting vesicle trafficking [9, 10]. However, despite the similar brain phenotype, FLNA patients do not have extrapyramidal movement disorders or microcephaly. Speculatively, in ARFGEF2 neuronal migration may be more severely affected due to disruption in GABA(A) receptor function in the embryonic period, as GABA(A) antagonists have been shown to impair neuronal motility in rodents in vitro and in vivo [11, 12].
###end p 16
###begin p 17
###xml 131 132 131 132 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 297 299 297 299 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 385 392 <span type="species:ncbi:9606">patient</span>
Microcephaly can be due to diminished neuronal proliferation and BIG2 inhibition in vitro experiments seem to suggest this occurs [1]. Increased apoptosis can also cause microcephaly and atrophy. Other BIG2 inhibition experiments show some signs of endoplasmic reticulum stress in cultured cells [13]. Possibly, ER stress increases susceptibility to apoptosis in specific neurons. Our patient's normal occipito-frontal circumference at birth shows that congenital microcephaly is not obligatory. Why the putamen should show a specific sensitivity for neuronal loss is unknown.
###end p 17
###begin p 18
###xml 128 129 128 129 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 131 132 131 132 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 213 214 213 214 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
Finally, ARFGEF2 is expressed postnatally and neurotransmitter receptor function can be impaired by defective exosome function [3, 6]. Disruptions in the recycling of receptors also hinder dendritic arborization [9]. This may have contributed to the movement disorder.
###end p 18
###begin p 19
###xml 144 151 144 151 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Our patient is compound heterozygote for two new mutations and new patients are needed to determine if a genotype-phenotype relation exists for ARFGEF2 mutations.
###end p 19
###begin p 20
###xml 35 42 35 42 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">ARFGEF2</italic>
###xml 203 210 <span type="species:ncbi:9606">patient</span>
BPNH caused by autosomal recessive ARFGEF2 mutations is more than an anatomical malformation. We suggest that the clinical features of the choreadystonic movement disorder, BPNH, and microcephaly of our patient can be understood in the light of abnormal vesicle transport resulting in neuroependyma disruption, decreased proliferation of neurons, and/or increased sensitivity to apoptosis and lifelong exosome dysfunction affecting neurotransmitter receptor function and neuronal development.
###end p 20
###begin title 21
Electronic Supplementary Material
###end title 21
###begin p 22
Below is the link to the electronic supplementary material.
###end p 22
###begin p 23
de wit Sample 3 (MP4 9088 kb)
###end p 23
###begin p 24
###xml 0 21 0 21 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Conflicts of interest</bold>
Conflicts of interest This study was supported by the Revolving Fund of the Erasmus MC. The authors have no conflict of interest.
###end p 24
###begin p 25
###xml 0 11 0 11 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 25
###begin title 26
References
###end title 26
###begin article-title 27
###xml 107 112 <span type="species:ncbi:9606">human</span>
Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex
###end article-title 27
###begin article-title 28
Redundant roles of BIG2 and BIG1, guanine-nucleotide exchange factors for ARFs in membrane traffic between the TGN and endosomes
###end article-title 28
###begin article-title 29
Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake
###end article-title 29
###begin article-title 30
The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the beta subunits of the GABA receptors
###end article-title 30
###begin article-title 31
GABAA receptor associated proteins: a key factor regulating GABAA receptor function
###end article-title 31
###begin article-title 32
The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles
###end article-title 32
###begin article-title 33
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations
###end article-title 33
###begin article-title 34
Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia
###end article-title 34
###begin article-title 35
Overlapping expression of ARFGEF2 and Filamin A in the neuroependymal lining of the lateral ventricles: insights into the cause of periventricular heterotopia
###end article-title 35
###begin article-title 36
A noncanonical release of GABA and glutamate modulates neuronal migration
###end article-title 36
###begin article-title 37
GABA-A receptors regulate neocortical neuronal migration in vitro and in vivo
###end article-title 37
###begin article-title 38
Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1
###end article-title 38
###begin p 39
###xml 0 33 0 33 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 39
###begin p 40
The online version of this article (doi:10.1007/s10048-009-0192-2) contains supplementary material, which is available to authorized users.
###end p 40

